Life ScienceCompany
AMAL Therapeutics SA Ownership
Who owns AMAL Therapeutics SA?
AMAL Therapeutics SA is owned by Boehringer Ingelheim. It was acquired on July 15, 2019.
AMAL Therapeutics SA Business Overview
Where is AMAL Therapeutics SA headquartered?
AMAL Therapeutics SA is headquartered in Geneve, Switzerland.
What sector is AMAL Therapeutics SA in?
AMAL Therapeutics SA is a life science company.
Life Science M&A Summary in 2019
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.
Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.